“I think this kind of technology could have a major effect and revolutionize various aspects of medicine, including birth control,” Professor Bob Langer says in an interview with Mallika Marshall of WBZ about technology from the biotech firm MicroCHIPS that could allow for implantable, remote-controlled, birth control.
Boston Globe reporter Scott Kirsner explores the history of MicrChips, an MIT startup that has made headlines recently with the news that the company is developing a remote-controlled, implantable contraceptive chip.
Guardian reporter Oliver Wainwright reports on the new remote-controlled contraceptive chip developed by MIT researchers. “Someone across the room cannot reprogramme your implant,” says Dr. Robert Farra. “Communication with the implant has to occur at skin contact-level distance. Then we have secure encryption. That prevents someone from trying to interpret or intervene between the communications.”
“We may be just years away from the longest-lasting and most hassle-free contraceptive ever invented,” writes Eliana Dockterman for Time about new implantable contraception being developed by MIT startup MicroCHIPS.
“The concept was conceived two years ago when Bill Gates visited Robert Langer’s MIT lab,” writes Sarah Gray for Salon about a new implantable, contraceptive microchip. The chip can be controlled remotely and lasts for 16 years.
Rachel Raczka writes for Boston.com about MIT startup MicroCHIPS’ new remote-controlled contraceptive device. The implantable microchip releases levonorgestrel, an active ingredient in certain forms of oral contraception, and can be turned on or off with the flip of a button.
BBC News reporter Dave Lee writes that MIT researchers have developed an implantable contraceptive chip that can be controlled via remote control. "The ability to turn the device on and off provides a certain convenience factor for those who are planning their family," explains Robert Farra.
Dr. Keith Isaacson of Newton-Wellesley Hospital discusses the hospital’s collaboration with MIT on gynepathology research with Andrea Timpano of Boston Magazine. Isaacson, with MIT researchers, developed a smartphone app that helps endometriosis patients monitor their condition.
Amanda Schaffer reports on Professor Linda Griffith’s work with endometriosis in The New Yorker, explaining how Griffith, “analyzed how a whole network of cells and molecules interacts in some patients to cause inflammation, which triggers pain and may also spur the disease’s progression.”